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ABSTRACT

Thirty-one million Americans experience low-back pain (LBP) at any given time
in their lives.1 LBP is the single leading cause of disability worldwide and its prevalence
in the US is approximately 80%.2 The intervertebral disc (IVD) is composed of the nucleus
pulposus (NP), a gelatinous core that resists compressive loading through the generation
of intradiscal pressure (IDP), and the annulus fibrosus (AF), which has concentric sheets
(lamellae) of aligned Type I collagen which alternate the fiber-preferred direction with
each subsequent layer allowing for resistance to IDP, and tensile and torsional loads.
Although, IVD degeneration (IVDD) and herniation (IVDH) represent two independent
pathological mechanisms; they both contribute significantly to LBP. Potential clinical
treatments for herniation and degeneration include discectomy (removal of the herniated
IVD fragments) and NP arthroplasty, respectively. However, both treatment options are
insufficient by themselves; especially when the defect in the outer AF is >6mm.3 We
hypothesized that an ideal AF patch to be used for repairing the AF and promoting its
regeneration can be developed from adjoined sheets of decellularized porcine pericardium
due to its aligned type I collage fiber architecture resembling the native AF structure. The
objective of the research presented herein was to illustrate the feasibility of developing a
biomimetic patch to biologically augment AF repair.
Porcine pericardium was harvested at a local abattoir and decellularized in order to
minimize potential immunological reactions.4 Decellularization was confirmed via,
Hematoxylin & Eosin (H&E), agarose gel electrophoresis, nanodrop quantification and
immunohistochemistry for the removal of the porcine antigenic epitope, alpha-gal. Tensile
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mechanical testing was performed on single-ply AF sheets and fresh pericardium in the
fiber preferred and cross-fiber orientation to determine tensile mechanical properties and
to compare values reported in literature for a single AF lamellae, and to ensure the modified
decellularization procedure did not alter the mechanical strength of the tissue. Ball burst
test of multi-laminate AF patches composed of decellularized pericardial layers was
performed to assess the maximum burst strength the pericardium could withstand and the
necessary number of layers needed to resist the IDP generated by the NP exerted as hoop
stresses within the AF. Production of ply-angle-ply multi-laminate AF patches were
constructed via the use of decellularized pericardium sheets were sewn in conjunction with
a backing material, surgical suture and a sewing machine in order to develop a scalable
manufacture methodology. Cytocompatibility of the AF patches was verified through a 15
day in vitro pilot cell study to assess bovine AF cell viability and proliferation when seeded
on the patch.
Results to be presented illustrate a repeatable method for developing a multilaminate ply-angle-ply AF patch. The AF patch demonstrates comparable tensile elastic
modulus to native AF, adequate burst strength and cytocompatibility to be considered a
potential option for AF tissue engineering. Taken together, results suggest that the multilaminate ply-angle-ply AF patches may be suitable for use as an adjunct to nucleus
arthroplasty implantation as an early-stage treatment for patients demonstrating the onset
of IVDD or as a sequestration device in patients undergoing discectomy following large
IVDHs to help mitigate the risk for re-herniation.
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CHAPTER 1
LITERATURE REVIEW

1.1 Clinical Significance:
Intervertebral Disc Herniation & Degeneration
Thirty-one million Americans experience low-back pain (LBP) during their
lifetime.1 LBP is the single leading cause of disability worldwide, according to the Global
Burden of Disease 2010, and its prevalence within the United States (U.S.) is
approximately 80%.2 It is estimated that Americans spend a minimum of $50 billion
addressing LBP (i.e. pharmaceuticals, doctors’ visits, and physical therapy) each year.3
Back related conditions are an enormous economic burden, and are a frequent cause of
disability leading to annual healthcare costs that exceed $1 billion in the U.S.4 Back related
conditions typically include pathologies of the intervertebral disc (IVD): herniation and
degeneration. Greater than half of lumbar IVD herniation’s occur in active individuals
between age 20 - 40 years.5 IVD herniation is most commonly treated by discectomy, and
healthcare spending on lumbar discectomies for IVD herniation have been estimated to
exceed $300 million annually.6 Despite the 1,000,000 discectomy procedures performed
annually, patient satisfaction is approximately 75% at 1 year. Roughly 19% of these
patients need re-operation 9 years after the original procedure.7,8 There is a critical overall
risk of recurrent IVD herniation between 6%-24%,9 particularly in patients with a AF
defect that exceeds 6 mm10. Intervertebral disc degeneration (IVDD) is seen in
approximately 20% of people in their teens and then increases steeply with age, particularly
in males. Approximately 10% of 50-year-old IVD’s and 60% of 70-year-old IVD’s are
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severely degenerate.11 Spinal fusion based procedures have become the most common
treatment for severe LBP caused by IVDD. About 87% of spinal procedures in 2013 were
fusion-based, according to the research firm GlobalData and there were more than 465,000
fusion operations in the U.S. in 2011, according to the Agency for Healthcare Research
and Quality (AHRQ).12,13 The estimated cost of spinal fusion procedures were more than
$12.8 billion in 2011, according to AHRQ.13 However, spinal fusion may result in
detrimental long term results, such as adjacent segment degeneration and reduced spinal
range of motion.14

1.2 The Intervertebral Disc (IVD)

1.2.1

IVD Structure

The spine contains twenty three intervertebral discs (IVD’s); six in the cervical
region, twelve in the thoracic and five in the lumbar region. The largest IVD’s are located
in the lumbar region and are approximately 7-10 mm thick and 4 cm in diameter.15 The
IVD’s are responsible for one fourth the total length of the spinal column. The IVD’s are
the primary structural unit located between the concave articular surfaces of the adjacent
vertebrae.16 Each individual IVD is made up of three distinct regions: the annulus fibrosus
(AF), the nucleus pulposus (NP), and the cartilaginous endplate (CEP) (Figure 1). The AF
is the outermost region of the IVD that consists of concentric sheets of collagen which
provides structural support of the IVD and aids in its attachment to adjacent vertebral
bodies. The NP is the gelatinous core of the IVD which generates an IDP inside the
confined space of the AF. The CEP is a thin layer of articular cartilage that encompasses

2

the top and bottom of the IVD at the interface of the IVD and the adjacent vertebrae. The
three major biochemical constitutents of the IVD are water, fibrillar collagens and
aggrecan. The proportion and organization of these components vary considerably with

Figure 1: Structure of the intervertebral disc depicting the annulus
fibrosus (AF), the nucleus pulposus (NP), and the cartilaginous
endplate (CEP).58

position across the IVD with the NP having a higher concentration of water and the
proteoglycan, aggrecan, than other regions of the IVD.17 The IVDs are the largest
avascular/aneral sturctures in the human body.16 Since the IVD’s are avascular they have
a very low cell density in comparisson to other tissues, with cells occupying approximately
0.25-0.5% of the tissue volume. Although there are few cells, their role is vital as they are
responsible for sythesizing and maintaining an appropriate macromolecular compostion.
The activity of IVD cells can be regulated by growth factors, cytokines, and mechanical
stress.
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1.2.1.1 Nucleus Pulposus
The centrally located nucleus pulposus (NP) (Figure 2) contains randomly oriented
network of collagen type II and elastin fibers (sometimes up to 150 μm in length), which
are arranged radially; these fibers are embedded in a highly hydrated aggrecan-containing
hydrogel.15 The NP is gelatinous due to its high water and aggrecan content. The aggrecan
is a large aggregating proteoglycan consisting of a protein core to which up to 100 highly
sulphated glycosaminoglycan (GAG) chains, principally chondroitin and keratin sulphate,
which are covalently attached.17 The GAGs are highly negatively charged which attracts
the binding of small positively charged cations into the tissue to balance the net charge.
These ions then encourage the infiltration of water through osmosis into the NP. The water
content can be as great as 85% in young people and decrease by 10 - 15% during aging.18
This influx of water exerts an intradiscal swelling pressure on the collagen network (Figure
2). It’s the retention of aggrecan and the low permeability of the NP extracellular matrix in
compression within the collagen network that causes the swelling pressure reserved for
resisting compressive load with minimal deformation.19 In order to maintain osmotic
equilibrium, fluid is expressed out of the NP as pressure increases, but because of the IVD’s
size and low hydraulic permeability, water loss is slow and returning to equilibrium takes
many hours.17 This unique resistances to compression from axial loading forces allows the
NP to act as a shock absorber to prevent injury to the vertebral body.16
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The cells within the NP are chondrocyte-like, being rounded and segregated from
each other by the extracellular matrix (ECM).17 The cells synthesize collagen type II and
type X, express hypoxia-inducible factors, and secrete proteases and interleukins.20

Figure 2: Depiction of the function of collagen fibers and proteoglycans in the nucleus
pulposus.59

1.2.1.2 Annulus Fibrosus
The annulus fibrosus (AF) is made up of a series of 15–25 concentric sheets, or
lamellae, with the collagen fibers lying parallel within each lamella. The fibers are
orientated at approximately 30° to the horizontal axis, alternating direction with each
adjacent lamellae (Figure 3).15 The fiber alternating lamellae is commonly referred to as
a ply-angle-ply architecture. The AF has a much higher collagen and lower water content
as compared to the NP.21 The AF consists of water (65-90%), collagen (50-70% dry
weight), proteoglycans (10-20% dry weight) and non-collagenous proteins (e.g. elastin).22
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The spaces between the lamellae are called interlamellar septae, and they contain
proteoglycans, versican, and water that help decrease friction between the layers during
movement of the spine. The lamellae are also interspersed with elastin fibers which help
the IVD to return to its original arrangement following bending of the spine.23 The outer
AF lamellae are composed of majority type I collagen but type II collagen increases
towards with inner lamellae. At the periphery, some of the annulus fibers pass the endplates
to penetrate into the bone of the vertebral body in structures known as “Sharpey’s fibers”.
This highly fibro-cartilaginous structure allows the AF to exhibit a complex anisotropic
behavior to resist the forces exerted on it during compression, bending and tension.22 The
unique alignment of the fibers within each lamellae resists high tensile forces during

Figure 3: Depiction of the ply-angle-ply multi-laminate concentric sheets
and the collagen fiber orientation within the annulus fibrosus.60
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flexion or extension of the spine. The AF is responsible for the stable structure of the IVD
during bending, twisting or compression of the spine.
The cells within the outer AF are thin and extend along the collagen fibrils, similar
to tendon cells or fibroblasts. Towards the inner AF, the cells tend to have a more rounded
morphology.16 The AF cells have been shown to produce predominantly type I collagen
and versican along with lesser amounts of type II collagen. Similar to the NP cells, they
also respond to mechanical forces on the spine.

1.2.2

IVD Function

The human spine consists of 24 movable vertebrae that are stacked on top of one
another, and joined through the IVD’s. These interlocking vertebrae provide structure to
the torso, and provide protection to the spinal cord nerve and nerve roots. Each IVD and
its two adjacent vertebrae provide motion with six-degrees of freedom in flexion-extension,

Figure 4: Schematic illustrating the compression of the nucleus pulposus
(NP) and its redistribution of forces onto the annulus fibrosus (AF) and
vertebral bodies (VB).
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lateral bending, and axial rotation. The IVDs are flexible to allow for bending and twisting,
but also act as shock absorbers during axial compression. This is done by keeping the
vertebrae separated when under high compression forces. The structure of the IVDs is
designed such that as the spine undergoes loading, it is resisted by the IDP generated by
the confined NP. The NP then distributes pressure radially to the AF fibers generating hoop
stresses within the AF and thus keeping the AF structure taut and therefore contributes to
the stabilization of the function spinal units (Figure 4). The unique AF architecture is
formed from 15-20 concentric layers of collagen sheets with an aligned ply-angle-ply
orientation responsible for opposition of tensile and torsional loads generated during
bending and twisting. When a compressive force is applied to the spine the IVD height
gradually decreases as the load is dissipated, but over time it will regain its full height due
to the hydrophilic properties of the NP. This is observed throughout the day as human
height decreases due to constant muscle and gravitational forces creating compressive
forces on the IVD’s, but after sleeping throughout the night a person’s height is restored.
Typically, healthy IVD’s are so strong that in compression, the vertebral body has the
tendency to fail in compression before the IVD’s rupture.16
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1.3 IVD Herniation vs. Degeneration

1.3.1

Overview

Intervertebral disc herniation (IVDH) is a common condition that frequently affects
the spine of young and middle-aged patients.4 Majority of IVDH’s are in young healthy
IVD’s between the ages of 20-40 years old. A herniated IVD, commonly known as a
slipped or ruptured disc, occurs when the nucleus pulposus (NP) is extruded through some
or all of the lamellae of the annulus fibrosus (AF) (Figure 5). It most frequently occurs in
the lower back, specifically at the L1-L5 IVD’s, and is the most common cause of low
back pain (LBP), as well as leg pain (sciatica).4 IVDH is commonly caused when a sudden
and extreme load is exerted on a young, healthy spine. Herniation is directly related to the
degree of degeneration of the IVD.24 Due to the changes exhibited in the NP of a
degenerated IVD (including NP dissection) only healthy or mildly degenerated IVD’s can

Figure 5: Depiction of a herniated disc (left) and stages of disc herniation (right).61,62
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result in a herniation.24 Causes of herniation may include accidents, such as car wrecks,
work injuries, or sport related impacts. These injuries result in the IDP of the NP exceeding
the strength of the AF lamellae resulting in the NP perforating between the fibers into the
surrounding area of the spine. When the NP is extruded, the IVD height then decreases due
to a loss of pressure inside the NP. The pressure is lost due to the decrease in NP material,
and the ruptured AF can no longer support the IDP or compressive load. There are varying
degrees of herniation (Figure 5), the first is prolapse, which is when the AF and NP extend
into the surrounding area, but the NP has not broken through the last layers of the AF. The
second type is a herniation where the NP has broken through all of the AF layers. The third
type is sequestration where there are fragments of the NP that have broken off from the
main herniation into the surrounding tissue. The extruded NP initiates the inflammatory
cascade resulting in irritation to the surrounding nerves and tissues. All of these herniation
types result in bulging into the surrounding tissue and have the potential to compress the
nerve root. These herniation’s can also cause a decrease in IVD height which may result in
back pain and sciatica due to nerve root compression in between the vertebral foramina.
Lumbar discectomy, removal of the extruding NP, is the most common surgical procedure
performed for patients suffering from back pain and sciatica.4 The procedure is performed
despite exhibiting potential long term negative effects on adjacent vertebrae and IVD’s.
Discectomy is also associated with an increased risk of re-herniation when the AF defect
is greater than 6 mm due to the inability of sutures to efficiently close the defect. 25 This
surgical procedures effectiveness could be improved with the use of an AF closure device.4
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As the body ages, the IVD ages naturally which slowly alters the natural
biochemical composition of the IVD, and its biomechanical ability to resist compressive
forces. By allowing the IVD to experience excessive mechanical loading, this can rapidly
alter the biochemical composition of the spine leading to IVD degeneration (IVDD)
(Figure 6). IVDD commonly initiates in the NP resulting in an altered stress distribution
during compression from the NP to the AF which ultimately damages the entire functional
spinal unit. IVD degeneration is a cell mediated process dependent on mechanical loading
of the spine, age, genetics, biochemical influences, and smoking.26 Evidence of spinal
degeneration is present in between 90%-100% of individuals over the age of 63.26
Degeneration implies a degradation of structure and/or function that is superimposed on
top of the normal ageing process.27 Stimuli such as increased load, osmotic pressure, and
reduced glucose have shown to lead to altered cell function, resulting in cells that not only
stop dividing and replicating, but increase production of cytokines and matrix-degrading
enzymes. These enzymes of the metalloproteinase (MMP) family, are all capable of

Figure 6: Depiction of disc degeneration.63
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degrading proteoglycans and collagen, resulting in the loss of GAGs and IVD function.
Cellular production of MMPs is supported by an acidic environment (such has been
reported in degenerate IVD’s), while GAG synthesis is drastically reduced, thereby leading
to a vicious spiral of degeneration because matrix construction is outpaced by its
destruction.26 IVDD leads to a decreased IVD height which can result in nerve root
impingement causing pain in patients’ back and/or limb. The most common surgical
solution for IVDD is spinal fusion. Spinal fusion is an end-stage treatment used in patients
with debilitating pain and spinal instability. In recent years, there has been 6-fold increase
in the number of spinal fusions performed, which is alarmingly high.

1.3.2

Surgical Solutions & Shortcomings

LBP and sciatica symptoms are initially treated with over-the-counter pain relievers
and muscle relaxants.28 Depending on the severity, antidepressants and prescription pain
medication can be used for more severe and chronic pain.28 If pain persists for at least six
weeks despite treatment, patients are commonly referred to a specialist. From there a
specialist generally prescribes an MRI to more accurately evaluate the potential causes of
the patients’ symptoms. Dependent on what is depicted in the MRI the specialist discusses
potential physical therapy and surgical options. MRI images can show IVDD due to the
decrease in water content resulting in the IVD to be blacker (Figure 7). MRI images can
also show IVDH due to the NP perforating out past the AF edges and into the surrounding
tissue (Figure 7).23 IVDD and IVDH have some separate and overlapping treatment
options. The most common treatment option for IVDH is lumbar discectomy, the removal
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of the herniated NP.29 Despite high rates of safety and success in relieving pain and
improving function, between 10% and 30% of discectomy patients continue to experience
unsatisfactory results such as a loss of IVD height and recurrent IVDH.29 In order to
mitigate re-herniation rates, traditionally a discectomy with removal of as much NP as
possible was recommended. This has been shown to lead to long term IVD disruption due
to loss of IVD height which transfers loads radially to the AF and facet joints.18,30 In
response to these long term effects, a limited discectomy was proposed to only remove the
extruding NP without the internal NP. This led to an increased incidence of re-herniation.
It has been shown that the rate of re-herniation after limited discectomy was greatest in
patients with a large AF defect, > 6mm.25 Currently, it has been suggested that a barrier or
patch to close these large AF defects should be implemented to potentially reduce the high
re-herniation rates.
Another potential surgical treatment for IVDH is the implementation of a NP
replacement. An NP replacement could increase IVD height and restore compressive
resistance to the IVD. A common concern with NP replacements is the process of inserting
them into the IVD creates a defect in the AF. Due to this defect the use of NP replacements
have been limited because of the potential to migrate out of the IVD. In order to utilize NP
replacements a restraining structure is required inside the IVD. If the AF defect could be
contained with a barrier or patch, an NP replacement could be implemented more readily.
NP replacements are also being investigated for the treatment of IVDD. Since IVDD leads
to a loss of functional NP and IVD height, an NP replacement could help mitigate those
problems as an early stage intervention. IVDD is most commonly treated with spinal fusion
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which is a destructive end stage treatment. Spinal fusion requires the complete removal of
the degenerated IVD and the insertion of a spacer (synthetic or autologous bone) to keep
adjacent vertebrae appropriately spaced in the absence of the IVD. Spinal fusion has been
shown to lead to long term negative effects on adjacent IVD’s due to unnatural loading
which results in increased IVDD at adjacent levels.

Figure 7: MRI of normal, degenerated, and herniated
IVD’s.64
Also on the market are medical devices specific for the closure of annular defects
for after IVDH and discectomy. Devices similar to Xclose ™ from Anulex Technologies
Inc. (Minnetonka, MN, USA) use a system of sutures to attempt to close the annular defect
and restore IDP. The Xclose consists of two non-absorbable braided surgical 3-0 sutures
and T-anchor assemblies, connected together with a loop of 2-0 suture. The 2-0 suture loop
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is used to facilitate tightening, drawing the 3-0 suture assemblies together, thereby reapproximating the tissue.31 While sutures do provide closure of the defect edges they do
not create a sealed edge to completely prevent IDP leakage and therefore cannot reestablish
the necessary IDP.32 They are also limited in stability by the integrity of the adjacent
annular structure. Other devices take a different approach, like the Barricaid annular
closure device by Intrinsic Therapeutics Inc. (Woburn, MA) which acts as a ‘plug’ in the
annular defect to reestablish the integrity of the AF. It is composed of a multi-layer,
flexible, woven polyester mesh with a titanium anchor which is fixed to the proximal
endplate.33 The Barricaid has been shown to almost restore IVD height but does not allow
for tissue regeneration or remodeling.
Current research suggests that treatment options for both IVDD and IVDH could
be improved through the use of a patch for an intact AF in adjust with a NP replacement to
restore IVD function. This treatment combination could be used for IVDH after discectomy
to restore IVD height and prevent re-herniation. It could also be used in IVDD to restore
IVD height and decrease associated pain with nerve root impingement.

1.4 AF Tissue Engineering

1.4.1

Overview

Tissue engineering (TE) of the IVD is an up and coming field, but it is still in its
early stages. Many areas are being rapidly researched to find the best solution for
repairing/regenerating/replacing all or part of the IVD. Current areas of interest are cell-
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based therapies, graft transplants, and engineered scaffolds. IVD graft transplants seem
most promising but allografts are not an option due to a limited donor supply of healthy
discs because most IVDs have some form of degeneration by the age of 60, and also have
the potential to transmit disease.34 When engineering an IVD scaffold it is vital to
remember the NP and AF perform very different functions and will most likely require two
separate materials to satisfy these functions. Previous research has shown promising results
for NP replacements however, TE of the AF has proved to be challenging due to its highly
aligned architecture. An AF scaffold needs to mimic the biological characteristics of the
native AF with a highly aligned ply-angle-ply multi-laminate architecture. This
architecture is crucial for the scaffold to have suitable mechanical strength when comparing
it to the native AF. The scaffold should withstand spinal bending, torsional forces and IDP
generated inside the NP. The scaffold should allow for normal spinal motion and not
disrupt adjacent vertebra or IVD’s. This must all be maintained while also being
cytocompatible. The scaffold needs to allow for cell viability, proliferation, and promote
tissue regeneration/remodeling by those cells. A major concern is the lack of nutrients in
the IVD environment, and its potential effect on these cells inside the scaffold which still
needs to be addressed. Currently, most research is focused on a combination of the
scaffolds and cells.

1.4.2

Cell Sources

The ideal cell source would be healthy autologous cells, but this is not always the
most feasible option depending on the application. Human AF cells are difficult to come
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by because IVD’s are not readily available. Autologous AF cells are only harvested when
there is an injury to the IVD and surgery is necessary, but due to the injury these cells are
commonly unhealthy and do not make a reliable cell source.35 Human AF cells can also be
harvested from allogeneic sources, such as donated human IVD’s, although it is rare these
IVD’s do no exhibit some degree of IVDD. Allogeneic AF sources raise new concerns
such as the spreading of diseases and potential immunological reactions. Another potential
AF source is xenogeneic cells, most commonly from bovine, porcine, rabbit, and sheep
IVD’s. These cells are most commonly used for in vitro studies in place of human AF cells
since they are much more readily available. The animal AF cells allow researchers to
determine how their device would react with native or stem cell derived AF cells. These
cell are still not a viable option for implantation due to their immunological reactivity in
humans. Another consideration when using AF cells is the difficulty when culturing inner
and outer AF cells. It has been shown after 2 weeks in 2D culture AF cells lose their
distinguishable phenotypes.35 Although 3D culture helps cells stay differentiated, AF cells
do not survive well in synthetic materials such as alginate.35 In order for AF cells to be a
viable option in AF tissue engineering there are still many barriers that need to be
overcome.
A common cell source used in tissue engineering is stem cells. Stem cells are often
a viable choice due to their differentiation capabilities and the reliable ability to harvest
them. Until recently, stem cell focus has been on adult mesenchymal stem cells harvested
from bone marrow until new breakthroughs in adipose derived stem cells have been made.
Stem cells have the potential to differentiate into specific cells if they are presented with
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the appropriate chemical and mechanical signals. Research is still being performed on the
exact type of signals that will result in an AF cell phenotype in addition to determining
discriminatory AF phenotypic markers. If the stem cells are implanted into native or
decellularized tissue, it is presumed that the environmental signals will guide the cells to
the AF cell phenotype and it is thought that four genes: collagen type I & II, aggrecan, and
sox-9 could be used as an indicator of end stage AF cell phenotype.36

1.4.3

Scaffolds

Scaffolds can be considered any 3D structure that provides the structural support
for cell attachment and subsequent tissue development.37 Successful scaffolds allow for
cell attachment and migration, deliver and retain cells and biochemical factors, enable
diffusion of vital cell nutrients and expressed products, and exert mechanical and biological
influences to modify the behavior of the cell phase. Scaffolds investigated for AF tissue
engineering are composed of either synthetic or natural materials. Both natural and
synthetic scaffolds must take into account immunogenicity, architectural and mechanical
properties, biocompatibility and biodegradability, and method of graft delivery.38
Macroscopically an AF scaffold provides a structural matrix to support and distribute
mechanical loads and should mimic the unique ply-angle-ply architecture of the multilayered AF. Microscopically an AF scaffold provides a provisional matrix in a threedimensional microenvironment, to localize cells for cellular and molecular interactions
appropriate for cell survival and differentiation. These are two distinct features that must
both be considered when attempting to create an ideal AF scaffold.
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An emerging area for AF scaffold formations is through the method of
electrospinning. Electrospinning is a process in which a charged polymer jet is collected
on a grounded collector; a rapidly rotating collector results in aligned nanofibers.39
Electrospinning is advantageous for nanofibrous scaffolds due to the ability to highly align
the nanofibers. Electrospun scaffolds are one of the few possibilities to actually exhibit a
similar repeatability of the native AF architecture. Mimicking the native architecture is key
since function follows structure it exhibits mechanical properties approximate that of a
single AF lamella. A proposed benefit of the nanofibrous scaffold is its biodegradation, but
matching the rate of ECM production by cells with the scaffolds degradation rate is a
delicate balance. One that needs to be vetted by further research. Additional shortcomings
of using the electrospinning technique arise when trying to develop an entire AF construct.
The spun scaffold is developed in sheets ~1 mm in thickness which must be fixed together
to mimic the unique ply-angle-ply multi-laminate AF structure. Current literature does not
address this possible fixation method, or its potential to withstand significant compression
under spinal loading. Overall, electrospinning is a tedious and challenging method to
prefect, and it is not yet scalable to manufacturing size for marketing potential. Its potential
is present, although, more research must be done in order to present it as a viable AF
scaffold option.
Other proposed scaffolds exhibit similar pitfalls which need to be addressed. For
example, porous silk fibroin scaffolds from silk worm cocoons have been shown to
completely degrade in vivo in 2 years.40 The degradation time would need to be investigated
based on the native environment in the spine to ensure appropriate cellular ECM deposition
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during that time. Silk fibroin also does not mimic the native ply-angle-ply AF structure and
would need evaluation of its mechanical effects on the spines’ dynamic loading. . A poly
glycolic/lactic acid (PGA/PLA) copolymer scaffold have also been investigated, however,
these constructs do not exhibit similar architecture to the native AF and has been shown to
lose its rigid formation after only 12 weeks in an in vivo environment.41 Again, a poly-DL-lactide (PDLLA)/Bioglass, biodegradable poly(1,8-octanediomalate), and chitosan AF
scaffolds do not exhibit a similar architecture to the native AF.42–44 For an AF scaffold to
be implemented it should: 1) fill and/or repair the AF defect in order to contain the NP, 2)
allow fixation to the remaining AF, 3) allow for AF cell (or stem cell) viability,
proliferation and ultimately differentiation in order to synthesize and secrete the
appropriate ECM, 4) possess the characteristics anisotropic behavior of the native AF, 5)
maintain/restore the mechanical properties of the spinal motion segment, while 6) not
irritating or causing adhesions to adjacent spinal structures including the perineurium.45
Current proposed solutions only focus on overall mechanical properties but not the
influence of the properties on the surrounding native tissue, i.e. the innate need for a plyangle-ply multi-laminate architecture to appropriately redistribute mechanical forces
throughout the spinal unit. Proposed materials also do not report fixation methods to
surrounding tissues, and are commonly only in the beginning stages of investigation. In
summary, AF tissue engineering while it has promise, also holds many challenges to
researchers. The current challenges is in developing a scalable method to manufacture a
multi-laminate device that mimics the native architecture and strength of the AF. The
native AF architectures is responsible for distributing forces through the spinal unit without

20

negatively impacting surrounding tissue and is needed in an AF tissue engineered
replacement.

1.5 Towards the Development of a Biomimetic AF Patch

1.5.1

Justification

Current surgical treatments of patients with large AF herniation defects do not offer
long term beneficial solution. After discectomy, patients are commonly left with an
increased risk of re-herniation or negative side-effects to adjacent IVD’s. In order to reduce
these negative effects which can arise from discectomy, the patient’s need an intact AF.
Therefore, these patients would benefit from having an AF patch to reinforce the defect
zone to help mitigate the risk of re-herniation after discectomy.
Current treatments for IVDD are invasive end-stage treatments with potentially
detrimental long term results, including, adjacent segment degeneration in the case of
spinal fusion, and altered biomechanics and implant subsidence and migration in the case
of total IVD arthroplasty. Potential early-stage intervention treatments for IVDD are being
developed (i.e. NP arthroplasty); however, in order to effectively implement such a
technique, the AF needs to be intact. Taken together, patients’ suffering from IVDH and
IVDD may gain significant benefit from having a biomimetic AF patch available.
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1.5.2

Project Goal & Aims

The goal of this project is to develop a biomimetic patch that will biologically
augment AF repair. To achieve this goal, three specific aims were undertaken.
Aim #1: To develop and characterize a biomimetic AF scaffold via the decellularization of
porcine pericardium.
Hypothesis:

It was hypothesized that decellularized porcine pericardium would
make an ideal AF patch given its natural, fiber aligned collagen
sheet architecture, and to assess the tensile mechanical properties of
single-ply decellularized pericardial sheets.

Approach:

A) Porcine pericardium was harvested and decellularized via
chemical methods. Removal of porcine cellular remnants, DNA, and
the antigenic epitope alpha-gal was assessed via histology, DNA
quantification,

agarose

gel

electrophoresis,

and

immunohistochemistry, respectively.
B) Multi-axial burst strength testing and uniaxial tensile testing in
the fiber preferred and cross-fiber direction was performed on single
sheets of decellularized porcine pericardium.
Aim #2: To fabricate a multi-laminate scaffold with a fiber oriented direction.
Hypothesis:

It was hypothesized that porcine pericardium sheets could be
arranged in a ply-angle-ply architecture, and assembled into a multilaminate patch which mimics the native structure of the human AF.

Approach:

A) An AF patch formation method was developed.
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B) Fiber orientation of the ply-angle-ply multi-laminate construct
was evaluated.
C) Burst and suture retention strength of multi-ply AF patches were
evaluated.
Aim #3: To assess the cytocompatibility of the AF patch with representative AF cells.
Hypothesis:

It was hypothesized that the AF patch will support AF cell viability
and proliferation.

Approach:

A) Primary AF cells were isolated from bovine AF tissue and
expanded for experimentation.
B) An in vitro pilot study was performed to assess AF cell viability,
proliferation, and infiltration on multi-ply AF patches.
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CHAPTER TWO
MATERIALS AND METHODS

2.1 Materials
Agarose (Low-EEO/Multi-Purpose/Molecular Biology Grade), Ethidium Bromide
(1% Solution/Molecular Biology), exACTGene DNA Ladder, Deoxycholic Acid Sodium
Salt ( ≥ 99%), 1 mM Ethylenediaminetetraacetic Acid (EDTA), Sodium Azide, Phosphate
Buffered

Saline

(PBS)

Tablets,

Antibiotic/Antimycotic

(Ab/Am),

Dulbecco’s

Modification of Eagle’s Medium (DMEM) were all purchased from Fisher Scientific
(Fairlawn, NJ). Ethyl Alcohol (ETOH), Peracetic Acid Solution (32 wt. % in dilute acetic
acid), and Hydroxyproline Assay Kit were all purchased from Sigma-Aldrich Corporation
(St. Louis, MO). Proteinase K-solution (≥ 610 units/ml), Collagenase Type I (300 u/mg),
Ribonuclease A (≥ 97.1 Ku units/mg ), and Deoxyribonuclease I (≥ 3,480 u/mg DW) were
all purchased from Worthington Biochemical Corporation (Lakewood, NJ). LDH
Cytotoxicity Assay Kit was purchased from Pierce Biotech (Rockford, IL). DNeasy Blood
& Tissue Kit was purchase from Qiagen. Tris (Hydrxmthl) Aminometh 50mM, Triton 100x, and Dimethyl Sulfoxide (DMSO) were all purchased from VWR Scientific (Radnor,
PA). Trizol and Picogreen dsDNA Assay Kit were all purchased from Life Technologies
(Carlsbad, CA). Fetal Bovine Serum (FBS) (premium heat inactivated) was purchased from
Atlanta Biologicals (Norcross, GA).
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2.2 Methods

2.2.1 Porcine Pericardium Harvest & Decellularization
Decellularization procedure was adapted and modified from methods described by
Tedder et al.46 Porcine pericardium was collected at the time of slaughter from a local
abattoir. Excess connective tissue and extraneous adipose tissue were removed from the
pericardium using manual separation with tweezers and scalpel blades. All pericardium
were then placed in 1-2 beakers of distilled water (ddH2O) overnight and refrigerated at
4oC for cell lysis. Decellularization of pericardium was done to remove cellular DNA in
order to mitigate the native immune response within a patient’s native environment.
Decellularization solution contained 50mM Tris, 0.15% Triton x-100 (v/v), 0.25%
Deoxycholic acid-sodium salt, 0.1% 1 mM Ethylenediaminetetraacetic acid (EDTA),
0.02% Sodium Azide (NaN3) (pH 7.8). After cells were lysed overnight using hypotonic
solution, all tissues were rinsed once in fresh ddH2O, and drained using a metal strainer.
The tissues were then separated out into multiple specimen cups (~3 pieces of tissue per
cup dependent on size of tissue pieces), and 100 ml of decellularization solution was added
to each specimen cup. The cups were labeled and placed on a shaker at 150 rpm at room
temperature for 3 days. After 3 days, the tissues were drained, and 100 ml of fresh
decellularization solution was added to each specimen cup. The cups were returned to the
shaker at room temperature for another 3 days. Following the 6 day period, the decell
solution was discarded, and the tissues were rinsed in a series of washes for a total of 1
hour. Each specimen container was first washed for 10 minutes in 100 ml of ddH2O at
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room temperature on the shaker, and repeated once. The second wash was for 10 minutes
in 100 ml of 70% Ethanol (ETOH) at room temperature on the shaker, and repeated once.
The third wash was for 10 minutes in 100 ml of ddH2O at room temperature on the shaker,
and repeated once. Between each wash the tissue was drained using a metal strainer, and
the used solution was discarded. Next, an increased concentration of DNase/RNase
solution was prepared with DNase (stock = 3480 u/mg) 720 munits/ml, RNase (stock =
97.1 u/mg) 720 munits/ml dissolved in the appropriate amount of PBS with 5 mmol
concentration of Magnesium chloride (MgCl) (pH of 7.5). Then 100 ml of DNase/RNase
solution was added to each specimen cup. The cups were then placed in a 37oC
incubator/water bath with a shaker at 150 rpm for 24 hours. After 24 hours, the tissues were
rinsed by inverting tubes back and forth 12 times, and were strained twice in 100 ml of
ddH2O. The tissue was then sterilized in100 ml of 0.1% Peracetic Acid in PBS (pH 7.4)
for 2 hours on a shaker at 150 rpms at room temperature. All tissues were then rinsed in
100 ml of sterile PBS with changes every 30 minutes for a total of 2 hours on shaker at 150
rpms. The tissues were then combined into one pee cup and stored in 100 ml of 0.02%
sodium azide in PBS (pH 7.4) at 4oC until use.

2.2.2 Quantification of Pericardial Decellularization
Efficacy of decellularization was assessed by quantifying the amount of residual
porcine DNA using agarose gel electrophoresis and nanodrop spectrophotometry. A
Qiagen DNeasy Blood and Tissue Kit was used to extract total genomic DNA from both
decellularized and fresh pericardium samples according to manufactures instructions.
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(n=6/per group). Performing the agarose gel electrophoresis required two buffers: 10x TBE
Buffer (Tris, Boric Acid and 1mM EDTA) and an Electrode Buffer (10x TBE and dH20).
Formation of the 1% agarose gel (10x TBE, dH2O and Agarose) was done by microwaving
the agarose gel until clear (~2 min) and then allowed to cool to 60oC. Ethidium Bromide
was then added to the mixture before being poured into the gel mold. The comb was
inserted and air bubbles were pushed to the edge of the gel. Samples were prepared by
adding 5 µL of 6X loading dye to each 30 µL sample of DNA in a 2 ml microfuge tube.
Samples were centrifuged before loading in the agarose gel. The hardened gel was placed
into electrophoresis container with wells closer to the negative terminal. The chambers of
the container were filled with Electrode Buffer until the gel was completely submerged. 30
µL of the Standard DNA Ladder was loaded into the first lane of the gel with 30 µL of
DNA sample in each of the following lanes. The gel was run at 100 V, 58 mA for 60 min
and then the results were read.
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2.2.3 Tensile Mechanical Testing of Pericardial Sheets
Mechanical tensile testing was performed on fresh and decellularized pericardium
separated into two specific study groups. The representative samples in the first group were
cut from pericardial sheets in the fiber preferred direction (parallel with the fibers) while
the second group was cut in the cross-fiber direction (perpendicular to the fiber direction)
(Figure 8). A sample size of n=6 for each type of pericardium in each group was tested.
The tensile testing protocol was adapted from protocols used to test single human AF
lamellae for tensile elastic modulus47–49. Tensile testing was done to ensure comparable

Figure 8: Images depicting the two groups of
pericardium

samples.

(Left)

Fiber

direction. (Right) Cross-fiber direction.
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preferred

tensile elastic modulus to native human AF tissue. This is crucial to ensure the patch does
not disrupt the function of the native tissue.
All testing was done on a mechanical testing system (MTS) with a 100 N load cell.
The samples were first preheated to 37oC in a water bath for 30 minutes before testing. The
samples’ length, width, and thickness were all determined before testing using digital
calipers and ImageJ software (Figure 9A). The samples were prepped for testing by
attaching sandpaper to the ends of each sample before insertion into the MTS clamps to
prevent slipping (Figure 9B). Once inserted into the testing setup the samples were
preconditioned to 1 N with cyclic loading and tested to failure at a rate of 1 mm/min. Stress
strain data was recorded and plotted. The tensile elastic modulus was determined from the
linear region of the graph between 0.05 and 1.0 strain.

Figure 9: Representative images of MTS tensile testing setup process. (A) Determining the length and width of the
specimens. (B) Prepping samples with sand paper on both ends to prevent slipping during testing. (C) Image of MTS
machine fixture setup. (D) Image of tissue sample within testing setup.

2.2.4 Ball Burst Mechanical Testing of Single and Multi-layer Pericardium
The ball burst mechanical test was performed to determine the appropriate burst
strength, and the number of layers needed to withstand the IDP. The burst strength of
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Figure 10: (A) The MTS ball burst setup. (B) Close-up of ball and rod before entering clamped tissue system. (C) Tissue
after it had been burst by the ball.

decellularized pericardium sheets was determined using an Instron with a 1000N load cell.
The ball burst strength testing protocol was adapted from the ASTM D3786/D3786M:
Bursting Strength of Textile Fabrics Method. A custom designed testing fixture was made
to hold the pericardium sheets during testing (Figure 10). The testing apparatus was two
wooden blocks bolted together with a 6.25 mm diameter hole drilled through the center of
both blocks. On the inside surface of each block a neoprene square was glued down with
epoxy along with a layer of sandpaper to prevent the samples from slipping during testing.
The pericardium samples were centered over the hole in the block and bolted together. A
6 mm steel ball and rod was attached to the Instron head and was used to burst the
pericardium until failure under compression through the hole in the center of the testing
apparatus (Figure 10). Pericardium samples of 1, 2, 3 and 6 layers were tested with n=6 in
each group. The protocol recorded the displacement and the load the Instron head exerted
on the pericardium until failure. The load the Instron exerted onto the pericardium was
used to calculate the pressure the pericardium layers could withstand. In Figure 11, 𝑎 is
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the calculated contact surface [m] of the ball with the pericardium. F is the load [N] that
the Instron exerted on the pericardium at the time of burst. R1 and R2 were the radius [m]
of the ball (3 mm) and the pericardium (∞) respectively, where the pericardium was
considered a sphere with an infinitely large radius. E1 and E2 were the elastic modulus [Pa]
of the ball (200 GPa) and the pericardium (27 MPa, determined from tensile testing),
respectively. 𝜈 1 and 𝜈 2 were the poisson’s ratio of the ball (.27) and the pericardium (.3),
respectively.50–52 𝑝max was the maximum pressure [Pa] at the moment of burst of burst of
the pericardium.

Figure 11: The method of maximum burst pressure calculations. A sphere on a flat plate (a flat plate is a sphere with an
infinitely large radius). 65

2.2.5 Multi-laminar Ply-Angle-Ply Patch Formation
Multi-laminar ply-angle-ply patches were formed in order to mimic the native AF
architecture. Once the desired sheet orientation was achieved the necessary amount of
layers could be tailored to the desired burst strength. In order to attach multiple sheets of
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Figure 12: Representative diagram of the method for AF patch formation. A) The pericardium sheet fibers were aligned
and placed on the tissue backing. B) The layers were then sewn with the sewing machine. C) A patch plus tissue backing
was formed. D) The patch composite was then inserted into water to dissolve the tissue backing. E) Left was only the AF
patch.

pericardium together to form a multi-laminate ply-angle-ply AF patch a standard sewing
machine, tissue backing, and suture thread were used. The decellularized pericardium
sheets were first gently dried with a kimtech wipe to remove excess moisture. The fiber
preferred direction was then determined within each sheet using a light box. The sheets
were then layered to create the ply-angle-ply orientation. The multiple layers were then set
upon the tissue backing (fabric-solvy) for sewing in the sewing machine (Figure 12). The
tissue backing was needed to allow the sewing needle to puncture all the layers of
pericardium and to allow easier positioning of the layers in the sewing machine. A ~10 x
10 mm square was sewn into the layers to create the AF patch. The excess tissue backing
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was then manually removed with tweezers and the excess tissue was trimmed away from
the sutures with a scalpel blade. The patch was then added to a specimen cup of water for
30 minutes to ensure the degradation of any leftover tissue backing. This process was
repeated to make multiple AF patches.

2.2.6 Bovine AF Cell Isolation & Culture
Bovine tails were collected at the time of slaughter from a local abattoir. The IVDs
were dissected in half using mechanical shears. The NP was first removed in order to ensure
harvest of only the AF. The AF tissue was then removed using scalpel blades and washed
in a specimen cup containing 25 ml of sterile 2% antibiotic/antimitotic (Ab/Am) in
phosphate-buffered saline (PBS). The tissue was then vortexed to ensure thorough
washing. The tissue was then moved to the cell culture hood for manual mincing. The tissue
was transferred using sterile tweezers to a sterile petri dish. The tissue was minced to
between 2-4 mm using two scalpel blades and transferred to a 50 ml conical tube with 25
ml of collagenase solution (1% Ab/Am, 0.2% Collagenase Type I (125 units/mg dry
weight) and DMEM). Tissue was digested overnight (~18 hours) at 37 oC with a loose lid.
After digestion, the collagenase activity was stopped with pure FBS and gently mixed for
5-10 seconds. The digested solution was then passed through a sterile 100 µm cell strainer,
and the flow through was collected into a new 50 ml conical tube. The solutions were then
moved to a 15 ml conical tube for washing. The solution was centrifuged at 1000 rpms for
5 minutes. The supernatant was then removed and the cells were re-suspended in cell
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culture media (1% Ab/Am, 10% FBS and DMEM). The cells were then counted and plated
in a T175 at 3000-4000 cells/cm.2

2.2.7 Suture Pull Out Strength of AF Patch
The suture pull out strength of the AF patch was determined using 6-0 prolene
suture in a simple tensile test. The protocol method was developed from ASTM F2903 and
previous company guidelines. The tensile testing was done using an MTS machine with a
100 N load cell. The suture was inserted 2 mm from the edge of the patch. The bottom edge
of the patch was inserted into the bottom MTS clamp. The top ends of the suture was
secured to the movable head of the machine, creating a loop of suture. The suture was then
pulled to failure of either the suture or the patch at a rate of 75 mm/min.

2.2.8 Cytocompatibility of Multi-laminar Patches
Twenty-two 3-layer patches were prepared as described previously. In order for
the patches to be used in the cytocompatibility study, the patches were re-sterilized. First,
the patches were sterilized in a pee cup with 100 ml of 0.1% Peracetic Acid on a shaker at
150 rpms for 2 hours at room temperature. The patches were then washed in 100 ml of
sterile PBS for 1 hour (3 solution changes) on a shaker at 150 rpms at room temperature.
Next, the patches were neutralized in 100 ml of sterile 50% fetal bovine serum (FBS)/ 40%
Dulbecco’s Modified Eagle Medium (DMEM) + 1% antibiotic/antimitotic (Ab/Am)
overnight on a shaker at 150 rpms at room temperature.
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After sterilization, the patches were divided into multiple groups as shown in
Figure 13. Cultured bovine AF cells at passage 4 were seeded 1 x 106 cells in 75 µl of cell
culture media onto the top of 16 patches then incubated at 37oC for 3 hours. Every 20
minutes the run off media was pipetted back on top of the patch. After incubation, the
patches were then flipped using sterile tweezers and the same process was repeated for the
other side of the patch. After another 2 and a half hours of incubation, the wells were filled
with 2 ml of cell culture media. Three of the control patches did not receive cells, only cell
culture media. A separate three patches received 2 million more cells. These cells were

Figure 13: Cytocompatibility pilot cell study AF patch sample layout. Plate 1 – Day 6 and 15 patches. Plate 2 –
Day 21 and positive LDH control patches. Plate 3 – patches with cells seeded inside and on top of them.
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applied 1 million at a time to the inside layers of the patch with injection using a 27 gauge
needle and syringe.
After cell seeding (day 0), the patches were analyzed at day 6, day 15, and day 21
with media changes every 3 days. The patches were moved to new 12 well plates with fresh
cell culture media on day 3 to remove cells that did not attach to the patches. On day 3,
the positive LDH control patches were frozen in liquid nitrogen for 1 min and thawed for
1 minute (repeated 3 times) to induce cell death. The patches were then put back in fresh
media for 3 more days. On day 6, 8 patches were sacrificed. The media from all wells was
removed and saved in labeled 2 ml centrifuge tubes for Lactase Dehydrogenase (LDH)
analysis. The 8 patches were removed one at a time using sterile tweezers to a sterile petri
dish. The control and 4 designated day 6 patches were each cut in half. Half of each patch
were put into a labeled tissue cassette for histological analysis. The second half was then
cut in half again. Each piece was then put into labeled 2 ml centrifuge tube for analysis.
The whole positive LDH control patches were put into tissue cassettes for histological
analysis. At day 15, 5 patches were sacrificed. The media was again removed from all wells
and saved in labeled 2 ml centrifuge tubes for LDH analysis. The same removal and
analysis process was used at each time point. At all time points, picogreen and LDH
analysis were performed for the harvested patches to determine cell number and cell death,
respectively. At day 15, hydroxyproline analysis was performed to determine collagen
production.
A cell standard curve was made for picogreen to determine the amount of cells on
each patch. The picogreen DNA cell standard curve was made by harvesting cells from 2D
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culture using an appropriate detachment method. The cells were counted and re-suspended
in duplicate in appropriate cell number ranges (4 million, 2 million, 1 million, 500,000, and
250,000 cells) in 1 ml lysis buffer (10 mM Tris pH8, 1mM EDTA, and 0.2% (v/v) Triton
X-100). Cell samples were vortexed for 10 seconds every 5 minutes for half an hour,
keeping on ice throughout. The cells were then homogenized 10-15 times using a 21-guage
needle. Samples were the diluted to 1 in 10 with 90 µL of 1x TE Working Solution into the
wells of a black bottom 96-well plate. 100 µL of the prepared PicoGreen Working Solution
was then added to all wells and incubated at room temperature for 5 minutes wrapped in
aluminum foil. The fluorescence was measured at excitations at 460 nm and emission at
540 nm, respectively resulting in a gradient of cellular DNA based on cell number. A
similar process was used to determine DNA content on the AF patches. The patches were
first washed in PBS and then placed in the 1 ml of lysis buffer. All the previous steps were
then repeated.
A cell death standard was made using the positive LDH control patches as
maximum cell death. 3 AF patches were seeded with 2 million cells (described previously)
and cultured for 3 days in CCM. After 3 days, the cells were killed by submersion in liquid
nitrogen and then returned to fresh CCM for 3 more days to allow for sufficient LDH
production. The media was collected and measured for LDH in accordance with LDH
protocol resulting in a 2 million cell positive cell death control.
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2.2.9 Histological Analysis of Cell Seeded AF Patches
Representative samples were taken from corresponding studies, fixed in neutral
buffered formalin for 24 hours, embedded with paraffin, and sectioned at 5 µm thickness.
In order to visualize cellular material removal and tissue extracellular matrix, Hematoxylin
and Eosin (H&E) staining was used. Qualitative alpha-gal removal was confirmed using
immunohistochemistry (IHC) antibody Biotinylated Griffonia Simplicifolia Lectin I for
xenoreactive alpha-gal epitope. The Axio Zeiss Vert. A1 camera microscopy with Axio
vision SE64 Rel 4.9.1 software was using for imaging of slides.

2.2.10 Statistical Analysis
Results are represented as a mean ± the standard error of the mean (SEM). All
statistical comparisons between two groups were performed by two-tailed student’s t-test
of unequal variance or ANOVA. Significant differences were defined as p<0.05.
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CHAPTER 3
RESULTS

3.1 Decellularization of Porcine Pericardium
Decellularization of the pericardium was done to remove cells and cell debris
(including DNA) and the porcine antigen alpha-Gal in order to reduce the potential for an
immunological host response to the implanted constructs. The method of decellularization
was modified and adapted from Tedder et al. More, specifically, the DNase/RNase
concentration was modified after initial histological analysis showed small amounts of
residual DNA. The concentration of DNase/RNase was doubled to ensure complete
removal of all cellular DNA content. It was observed through histological H&E staining
that cellular nuclei are distributed throughout the fresh porcine pericardium ECM. Images
confirmed removal of all cell nuclei in the decellularized tissue sheets using this method
(Figure 14). The remaining ECM was intact and exhibited some tissue swelling as was
indicated by an increase in overall tissue thickness after the decellularization process.
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Figure 14: Representative H&E Images of porcine pericardium sheets. (A & D) Fresh tissue with cell nuclei
(B&E) Decellularized tissue without cell nuclei [ECM – Pink, Cell Nuclei – Blue]

IHC for alpha-Gal confirmed the presence of the porcine antigenic epitope in fresh
porcine pericardium tissue with positive staining (Figure 15) and its removal in the
decellularized tissue as indicated by a complete lack of positive staining. These results
suggest the successful removal of alpha-Gal through the modified decellularization
process.
Agarose gel electrophoresis (Figure 16) and nanodrop quantification (Figure 17)
results demonstrated significant reductions in cellular DNA content after decellularization
(p < .05). The agarose gel clearly showed the presence of high molecular weight cellular
DNA in the fresh porcine pericardium (as indicated by bright red bands) yet there was no
detectible intact DNA or low molecular weight fragments in the decellularized tissue
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Figure 15: Representative images of IHC stain for alpha-Gal. (A&C) Fresh porcine pericardium (B&D)
Decellularized porcine pericardium [Cellular Nuclei - Blue, Alpha-gal - Brown]

(Figure 16). Nanodrop results showed a 95.3% decrease in DNA from fresh to
decellularized porcine pericardium. The decellularized and fresh tissue were found to have
96.2 ± 13.4 and 2051 ± 112.7 ng DNA per milligram of sample dry weight, respectively
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Figure 16: Agarose Gel Electrophoresis Results. (Left) DNA content bands for fresh
and decellularized pericardium (Right) Standard DNA Ladder

Figure 17: Quantification of cellular DNA content in fresh and decellularized porcine pericardium tissue. * indicates a
significant difference (p< 0.05)
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3.2 Decellularized Pericardial Tensile Strength
Uniaxial tensile testing in the fiber preferred and cross-fiber direction was
performed on single sheets of fresh and decellularized porcine pericardium to ensure the
tissue had similar mechanical properties to the native human AF. Tensile mechanical
testing was performed on single-ply samples of pericardium to determine the tensile elastic
modulus of the material and ensure the modified decellularization procedure did not alter
the mechanical strength of the tissue. Tensile elastic modulus from 0.05 to 1.0 strain on the
linear region of the stress strain curves were calculated so that direct comparisons to
literature values could be made (Figure 18). Results indicated that the decellularization
method had no significant effect on the tensile elastic modulus of the porcine pericardium
(Figure 19) (p < .05). The cross fiber group had a slightly higher tensile elastic modulus
with the fresh and decellularized tissue having 36.77 ± 6.4 and 27.16 ± 4.64 MPa,
respectively. The fiber preferred group results again showed no significant difference
between fresh and decellularized tissue groups which had 16.97 ± 3.9 and 20.59 ± 4.91
MPa, respectively. There was no statistically significant difference between the
decellularized pericardium between the cross fiber and fiber preferred groups. The ultimate
tensile strength (UTS) was also determined from the tensile testing and showed no
significant difference between fresh and decellularized tissue groups in the cross fiber
direction which had 4.53 ± .934 and 4.54 ± .803 MPa, respectively. Although, there was a
significant difference found between the fresh and decellularized tissues UTS in the fiber
preferred groups which had 7.99 ± 1.46 and 4.62 ± 0.702 MPa, respectively.
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Figure 18: Representative stress strain curve of porcine pericardium tensile testing. (Top)
Entire stress strain curve during tensile testing. (Bottom) Linear region of the stress strain
curve from 0.05 to 1.0 strain.

Figure 19: Average tensile elastic modulus of fresh and decellularized porcine pericardium samples. No
significant difference was seen between fresh and decellularized tissue within each group (p<0.05).
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3.3 Decellularized Pericardial Ball Burst Strength
Ball burst testing of multiple pericardium layers was performed to assess the
maximum burst strength the pericardium could withstand and the necessary number of
layers needed to resist the IDP generated by the NP exerted on the AF as a hoop stress. The
burst strength of the pericardium layers was calculated using the peak load each group
could withstand before bursting. These peak loads were taken from the load/extension
graphs made for each sample tested (Figure 20). The burst strength of the groups showed
the strength increased significantly with the number of layers used (Figure 20). 1, 2, 3, and
6 layers all exceeded the internal IVD IDP of 2.3 MPa with 4.26 ± .40, 7.53 ± .52, 10.75 ±
1.47, and 18.49 ± .76 MPa, respectively. Statistical analysis performed with ANOVA
showed all test groups were significantly different from all other test groups (p<0.05).

Figure 20: Representative image of the load needed to burst a 3-layer AF patch.
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Figure 21: The maximum calculated burst pressure 1, 2, 3, and 6 layers of pericardium can withstand.
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3.4 AF Patch Formation
The AF patch formation method went through many different iterations in order to
succeed in the finalized AF patch formation methodology. Many methods required a
significant amount of tissue to form one small patch which limited the amount of patches
that could be made. A tissue backing was also required in order grip the material during
sewing. The pericardium tended to be slippery and difficult to hold in alignment without
the backing. The backing also provided enough stiffness for the needle to successfully
penetrate all layers. Initial patch formation was using a stiff fabric backing that was simple
to sew but proved to be difficult to remove without disrupting the AF patch. The next
method was using a kimtech wipe as tissue backing given it would tear easily from the
back of the tissue. This again proved to be unsuccessful due to residual kimtech wipe being
difficult to remove from beneath the tissue sutures. The patches needed to be sterilized and
leftover backing material would render that process ineffective. The final method was

Figure 22: (Left) Representative 22 3-layer AF patches in a specimen lid. (Right) One 3-layer AF patch 10.4 mm
in width.
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decided upon due to fabric-solvy’s fabric like feeling and dissolvability in water. This
method also allowed for smaller tissue to be used in order to conserve available
pericardium. Successful sewing of twenty-two 3-layer AF patches was done using the
finalized method (Figure 22). All 3-layered AF patches were ~ 8-12 mm with all of them
less than 1 mm thick.
The layers within the AF patches were specifically oriented during patch formation
to mimic the native AF ply-angle-ply architecture. Histological analysis of the 3-layered
AF patches showed the fiber orientation between each layer was difficult to determine even
though, each individual layer of the patch could easily be identified.
Suture pullout strength was investigated to ensure suitable strength of the AF patch
material to be fixed to the native tissue during implementation of the AF patch. The testing
results showed the 6-0 prolene suture failed at the point of contact with the patch before
any failure of the patch was evident. The average suture failure strength was measure to be
7.05 ± 1.23 N.

Figure 23: Representative H&E images of a 3-layer AF patch and fiber alignment.
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3.5 AF Patch Cytocompatibility
To determine the cytocompatibility of the AF patches, the patches were seeded with
bovine AF cells and cultured for 15 days in vitro. Histological images at day 6 and 15 time

Figure 24: Representative images of the 3-layer AF patches after 6 and 15 days in cell culture. Cells can be seen on the
surface of the patches. (A&C) Day 6 patch images (B&D) Day 15 patch images [Pink-ECM, Blue-Nuclei]

points showed a layer of cells on the outermost layer of the cultured patches (Figure 24).
No cellular migration into the AF patches was seen. Histology also showed no cells inside
specific patches even though the cells were manually seeded in between the layers. It was
also noted that there was a higher density of cells seen on the top surface of the patch than
on the bottom layer (facing the bottom of the well plate) of the patch.
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To determine cytocompatibility the amount of cell death and proliferation was
determined. The amount of LDH released into cell culture media by dead cells did not
increase over the course of the study, indicating the cell death did not progress. The results
showed only an 18.4 and 19.6% release of LDH at day 6 and day 15, respectively (Figure
25), which were not significantly different.

Figure 25: The amount of lactate dehydrogenase produced at day 6 and day 15. The control did not have any seeded
cells. The LDH positive (+) control was 100 % cell death of the seeded cells after attachment.
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The amount of DNA content on the cultured AF patches was determined using
PicoGreen analysis of a representative portion of the AF patch at day 6 and 15. DNA
content is directly related to the amount of cells on the AF patches which could be
approximated based on cell standards. The amount of DNA in 250,000 and 500,000 cell
was used to interpret the amount of cells found on the patches at day 6 and 15 (Figure 26).
There was no statistical increase found between day 6 and 15 but the data trended towards
an increase in DNA on day 15. The amount of DNA found at day 6 and day 15 were 0.264
± .081 and 0.361 ± .074 µg of DNA per ml, respectively. Taken together with the LDH
findings, it does not appear that the material induces an increase in cell death overtime thus
illustrating cytocompatibility.

Figure 26: The amount of DNA content on the cultured AF patches at day 6 and 15 using picogreen analysis. The
250,000 and 500,000 represent the DNA cell standards of 250,000 and 500,000 cells, respectively.
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CHAPTER 4
DISCUSSION

4.1 Decellularization of Porcine Pericardium
When performing tissue decellularization for biomimetic scaffold development, a
balance must be met between achieving complete decellularization and the preservation of
the ECM for biomechanical stability and function. The immunogenicity of acellular
matrixes must be eliminated before they are used for tissue engineering. Cells are the main
immunogenic factor due to histocompatibility antigens distributed on the surface of cell
membranes. Histocompatibility antigens are recognized by T cells, and the tissue is
attacked by the host after transplantation. So, before porcine pericardium is used as a
scaffold the cells were removed to avoid immune rejection and inflammation. The H&E
images showed that the modified decellularization protocol successfully removed the
cellular DNA fragments and the xenoreactive antigen in porcine tissue, alpha-Gal. These
findings were confirmed in the agarose gel electrophoresis which also did not detect any
DNA. A small amount of DNA, <100 ng/mg dry weight of tissue, was quantified in the
decellularized tissue using nanodrop. These results are in alignment with previous results
showed by Tedder et al. when using a similar decellularization protocol.46 While there has
been recent research into the amount of DNA that will illicit an intense immune response,
an exact ‘threshold’ has not yet been determined.53 It is well known that a decreased amount
of cellular ‘debris’ correlates to a decrease in immune response and by reducing the DNA
content by 95% this scaffold should not illicit a significant host immune response. Keane
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et al. clearly showed that an increase in DNA fragment size is associated with a more proinflammatory macrophage phenotype and based on the agarose gel decellularization results
the AF patch contains only low molecular weight DNA.

4.2 Decellularized Porcine Pericardium Mechanical Properties
Following decellularization, it was important to determine the effects on the biomechanical
properties of the decellularized scaffold. The tensile mechanical testing of the pericardium
showed that the decellularization process did not significantly alter the tensile elastic
modulus of the tissue since there was no statistical significance seen between the fresh and
decellularized tissue within each group. The determined tensile elastic modulus of the
decellularized tissue was also comparable to values reported for human AF in literature.54
The main distribution of forces throughout the AF are in tension during bending or twisting
on the spinal unit. Furthermore, AF layers have to resist hoop stresses developed due to the
IDP of the NP. As such, the AF patch should attempt to re-establish this key native
property. The decelled porcine pericardium tensile elastic modulus in cross fiber and fiber
preferred directions were 27.16 ± 4.64 and 20.59 ± 4.91 MPa, respectively. A single
lamellae of human AF tissue has a tensile elastic modulus range reported between 12 and
24 MPa.48 Variations in testing methods and sample size and directions may have
contributed to the slightly higher value in the cross fiber direction. Also, no statistical
significance was found between the decellularized tissue in the cross fiber and fiber
preferred groups. This could be due to the pericardium sheets having strong underlying
cross-linked fibers in the cross fiber direction resulting in the pericardium having a higher
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tensile elastic modulus in the cross fiber directions. These cross-linked fibers are suspected
to be stiffer but have a lower UTS. This was verified when the fiber preferred fresh
pericardium had a significant higher UTS when compared to decellularized pericardium.
The fiber preferred tissue has a lower tensile elastic modulus due to the collagen fibers
having an initially crimped structure that stretches out before providing resistance in
tension. The collagen fibers are less stiff than the cross-linking fibers in the fiber preferred
direction resulting in a lower tensile elastic modulus but they can resist a larger load,
resulting in a higher UTS.
The ball burst mechanical testing was deemed necessary to investigate the multiaxial burst strength of the decellularized pericardium. When the spinal unit is under
compression the NP exerts an IDP radially out onto the AF generating a tensile hoop stress
which impart is responsible for keeping the NP contained inside the IVD and adding
stability to the functional spinal unit.32 The pericardium needs to be able to withstand this
pressure from the NP in order to prevent expulsion of the NP. Testing was performed on
1, 2, 3, and 6 layers of pericardium in order to determine the appropriate number of layers
needed to adequately withstand the NP’s IDP. The highest reported IDP inside the NP of a
human volunteer was 2.3 MPa while picking up a 20 kg object.55 After each addition of a
pericardial sheet, a significant increase in burst strength was seen. The burst testing showed
that one layer of pericardium could potentially withstand the NP IDP (4.26 MPa) but in
order to incorporate a significant safety factor; 3 layers of pericardium may be beneficial
(10.75 MPa).
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4.3 AF Patch Formation
Once the adequate number of layers to resist the NP burst pressure was determined
3-layered AF patches could be developed. The AF patch formation method was vital in
mimicking the native AF tissue architecture. This native ply-angle-ply multi-laminate
architecture is responsible for distributing tensile bending and torsional forces throughout
the functional spine unit.56 By manually alternating the fiber preferred direction of the
pericardial tissue sheets, the ply-angle-ply orientation was developed. The sheets of
pericardium were then fixed in the determined orientation through sewing of the layers
together on a tissue backing. This tissue backing made the sewing method possible and was
ideal due to its complete dissolution in water. After the AF patch was sewn together it was
placed in water to dissolve off the tissue backing. This process allowed for no residual to
be leftover behind the suture and for the patch to be sterilized using a neutral pH peracetic
acid solution. The developed method of AF patch formation can be more readily scaled
for manufacturing methodologies compared to other AF TE methods.40,57
The confirmation of the 3-layered AF patches ply-angle-ply architecture was
difficult to demonstrated though histological images. We believe this is due to the patches
being sectioned on end and the fiber alignment being presented perpendicular to the view.
Polarized light was used to try and refracted the light based on the fiber orientation within
each layer of pericardium. This was predicted to result in a color alteration between the
individual layers. The images however did not present this color change. Even though
macroscopically the fiber orientation can be determined the method of histologically
imaging the fiber orientation needs to be developed further.
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After making the AF patches the suture pull-out strength needed to be determined
to ensure the mechanical strength of the patch to be sutured to the native AF tissue. The
suture pull-out test is vital for a TE material because the suture automatically creates a
puncture defect in the material where the stress will now increase at. The suture most
commonly used in spine surgery, 6-0 prolene, was used for testing. The testing results
supported that the AF patch has sufficient suture pull out strength given that the sutures
failed before the patch showed initial signs of failure.

4.4 Cytocompatibility of AF Patch
In conjunction with the use of scaffolds, AF TE requires the use of cells which have
the capacity to regenerate the ECM by maintaining the long-term homeostatic balance of
matrix turnover. The AF patch needs to be cytocompatible with these cells in order for it
to be integrated into the native host tissue. It’s our goal to make a construct that can
eventually integrate with the host tissue by allowing for infiltration of viable host AF cells.
This was tested through the seeding of bovine AF cell on the multi-laminate AF patches.
Human AF cells were not used due to the unavailability of human IVD’s that are not
damaged or degenerated. There is little feasibility in using healthy human native AF cells
since its harvest is destructive to the whole IVD. The bovine AF cells were used to test
cytocompatibility of the AF patch with cells with an end-stage phenotype found in the
native AF. Histological H&E images showed that the multi-laminate AF patch was
cytocompatible. Cells were seen in a uniform layer across the top outermost layer of the
AF patch at day 6 and 15. A lower cell density was seen on the bottom layer of the patch
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(facing the bottom of the cell culture well), suggesting that a longer resting time may be
needed before the patch is flipped to seed the other side to improve the amount of attached
cells. Since some cells were seeded on the inside patch layers, but cellular material was
only seen on the outermost layers, the cells on the inner layers of the patch may have died
and detached before histological images could be taken. This could have been due to the
dense ECM of the pericardium made it difficult for the cells to receive nutrients through
the layers of the patch. This could potentially be improved if pores could be created in the
patch layers for nutrient exchange. The cells undergo a natural rate of proliferation and
apoptosis which can be seen in the LDH and DNA content data. LDH is a cytosolic enzyme
that is released into the media from damage and acts as an indicator of cellular cytotoxicity.
The media is changed every three days so at day 6 and day 15 there is only 3 days’ worth
of LDH released into the media. Since the results showed no increase in LDH release
(~19%) for three days we can conclude the AF patch is not cytotoxic to the cells otherwise
we would likely observe a much higher percentage of LDH released to the media. The
amount of cells on the patches was determined using DNA content. Day 6 results showed
less than 250,000 were adhered to the patch. This is relatively low given the initial seeding
density, suggesting that the cell seeding method needs to be optimized. Although no
significant increase in the amount of cellular DNA between Day 6 and 15 was seen there
was a trend towards an increase in cell numbers on Day 15. This could be due to the low
number of cells that initially adhered to the patch, possibly an effect of too high of a media
volume used during seeding. While the use of AF cells allow for studying the effect of the
AF patch scaffold on cell behavior, the need for an alternative to AF cells arises in clinics
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due to the fact that xenogeneic cells are not a viable option and invasive surgical procedures
are required for AF cell isolation. MSCs could be an alternative for this application as they
are readily available from bone marrow or adipose tissue. However, research is still unclear
of the specific markers that direct stem cells to a discogeneic phenotype. The data of the
present study in terms of AF cell cytocompatibility shows that the cells can adhere to the
scaffold and remain viable for an extended period of time.
While cells were seeded in between the layers of 3 of the AF patch, results would
suggest they did not survive inside the patch. Histological H&E images did not show any
attached cellular material between the layers of the patch. This is most likely due to the
lack of oxygen and nutrient exchange inside the patch. The AF patches ECM is very dense
and nonporous and the sewn edges make them almost water tight. This could potentially
be solved by creating pores in the outer layers of the AF patch to allow for nutrient
exchange.
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CHAPTER 5
CONCLUSIONS & RECOMMENDATIONS FOR FUTURE STUDIES

5.1 Conclusions
Over the last few years there has been a significant push to develop AF TE devices
to create an early-stage treatment option for patients with IVDD or IVDH. Potential
scaffolds have continued to fall short when either mimicking the native AF ply-angle-ply
architecture or creating mechanically stable constructs. However, we have illustrated the
ability to repeatedly manufacture a unique ply-angle-ply multi-laminate AF patch which
could be used to create an intact AF. The AF patch contains suitable tensile elastic modulus
and burst strength to withstand daily spinal motion and pressures. It has also proven to be
cytocompatible with native AF cells and support cell viability. The multi-laminate AF
patch could be used in adjust with an NP replacement for IVDD or after discectomy to help
mitigate the risk of re-herniation. Further investigation into the attachment of the AF patch
to the native tissue needs to be carried out. Only then will we begin to establish the exact
method of implementation of this device.
5.2 Recommendations for Future Studies
The next logical step for future studies would be to perform a cellular study using
MSC’s to determine if they would be a viable options for implementation onto the AF
patch. Testing would need to be done to determine the cell’s differentiation capacity
towards an AF cell-like phenotype on the patch. It would also be a great study to perform
a long-term implantation of the AF patch to determine the response in vivo in the native
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environment of the IVD. Cellular response could be investigated for biocompatibility and
integration into the native tissue. It could also be key to develop a method to seed cells
successfully to the inside of the patch. The pericardium ECM is naturally too dense for
cellular migration through it but perforating the material could be a viable option if
mechanical stability is not sacrificed. Another key component of the native AF is GAG
content, while not as high as in the NP, it still plays a significant role in reducing friction
between the AF sheets. If GAG could be incorporated between the layers of the patch its
long term mechanical stability under spinal motion could potentially be preserved.
The order of importance in the future work should be taken into consideration as
follows:
1. Determine a method for creating pores in the pericardium and determine the
effect on the mechanical properties of the tissue
2. Perform another cell viability study on the inner layers of the patch after
successfully creating pores
3. Perform a cell differentiation study with MSCs on the patch
4. Incorporate GAG between the layers and determine the effect on the patch’s
mechanical properties
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